Video Shorts

Which Lung Cancer Experts Changed Your Mind at 2026 BTG Lung?

The Potential Effect of Daraxonrasib for Pancreatic Cancer Management

Examining a Novel Vaccine in Pancreatic Cancer

Discussing the Biggest Unmet Needs to be Addressed at 2026 BTG Lung

ATLG vs PTCy as GVHD Prophylaxis in Hematologic Malignancies

Outlining the Rationale for an ASCENT-07 Subgroup Analysis in Breast Cancer

Spotlighting the FDA Approval of Palbociclib Plus Trastuzumab for HER2+ Breast Cancer

Exploring the Potential Role of Cancer Vaccines in Pancreatic Cancer

Breaking Down Zanubrutinib Plus Sonrotoclax in MCL and Next Steps for the Combination

Explaining the Significance of the FDA Approval of Pembro Plus EV in MIBC

Targeting PRAME in Melanoma

Would You Rather? With Two Onc Docs!

Explaining the Rationale for the OPTIMA Trial in Early Breast Cancer

Highlighting the Importance of Innovative Glioblastoma Research

Unpacking Patient-Reported Outcomes in IMvigor011

Explaining the Next Steps for Studying Ipatasertib Plus Pembrolizumab in HNSCC

Important Expectations With Later Lines of Therapy in Older Patients with CLL

Exploring HSV-Based Immunotherapy in Advanced NSCLC

Appropriately Integrating AI Tools Into Breast Pathology Practices

Targeting CALR Mutations in MPNs

Examining Disease Recurrence in Postpartum Breast Cancer

How Can Data From PSMAtrack Inform Treatment in mHSPC?

How Daraxonrasib Is Shaping the Next Wave of RAS Inhibition in PDAC

The Significance of the MajesTEC-9 Trial in R/R Myeloma

Examining the Safety Profile of Detalimogene Voraplasmid in NMIBC

Who's Who? With Two Onc Docs!

ASCO 2026 Conference Check-In: With Jonathan Lee, MD, MSc and Despina Siolas, MD, PhD

Noting the Clinical Relevance of Sacituzumab Govitecan Plus Pembrolizumab in TNBC

Highlighting KEYNOTE-522 Data With Pembrolizumab in TNBC

Assessing Data for In Vivo CAR T-Cell Therapy in Myeloma